Karen Theresa Hernandez, PA-C

Karen Hernandez practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Karen Hernandez's NPI, 1427284413, was assigned on June 3, 2009. Karen Hernandez holds Florida license PA9104909.

Karen Hernandez's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Karen Hernandez's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Karen Hernandez is also affiliated with Boca Raton Regional Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Karen Hernandez to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Karen Hernandez practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Karen Hernandez's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Karen Hernandez is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Karen Hernandez is licensed in Florida.

Dmand AI lists tobacco use among the conditions Karen Hernandez treats.

CMS data shows 177 Medicare services from Karen Hernandez across 2 procedure codes in 2024, all of them office visits, for 149 Medicare patients. Medicare paid $8,155 for them. Every service was in an office.

CMS counts 149 Medicare patients who saw Karen Hernandez in 2024. The largest group is 65 to 74, with 79 patients. 75% of them have cancer, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Karen Hernandez's median patient age at 68, with 93% women.

In 2024, Karen Hernandez wrote 527 Medicare Part D claims for 162 patients. 80% of them were for generic drugs. CMS names the drug for 365 of them, across 14 drugs with 11 or more claims each, at $1,006,396 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Karen Hernandez for performance year 2024, reported as part of a group. Karen Hernandez accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Karen Hernandez as offering telehealth.

CMS Open Payments shows 121 general payments to Karen Hernandez from 25 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 92% of the total. Daiichi Sankyo Inc. paid the most, $796.